Related Experiment Video
Updated: Mar 22, 2026

A New Ex Vivo Model for the Evaluation of Endoscopic Submucosal Injection Material Performance
Published on: October 19, 2018
First Approval of Regenerative Medical Products under the PMD Act in Japan
Akihide Konishi1, Ken Sakushima2, Soichiro Isobe1
1Medical Device and Regenerative Medicine Product Evaluation Division, Pharmaceutical Safety and Environmental Health Bureau, Ministry of Health, Labour, and Welfare, 1-2-2 Kasumigaseki, Chiyoda-ku, Tokyo 100-8916, Japan.
No abstract available in PubMed .
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Drug Regulation
Drug Products: Biologics, Biosimilars and Interchangeables
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Clinically Relevant Drug Product Specifications: Methods of Establishment

